Related Experiment Video
Updated: Jul 8, 2026

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
Randomized clinical stroke trials in 2006
Meheroz H Rabadi1, John P Blass
1Burke Rehabilitation Hospital and Medical Research Institute, Weill Medical College of Cornell University, 785 Mamaroneck Ave., White Plains, NY 10605, USA. mrabadi@burke.org
Abstract:
This article reviews randomized control trials (RCT's) published in 2006 of various medications evaluated for stroke patients. These trials were primarily efficacy studies. These included aggrenox (an antiplatelet agent), magnesium (to treat arterial spasm after an aneurysmal subarachnoid hemorrhage), NXY (a free radical trapping agent) and albumin which were both tested as a neuroprotectant, amphetamine (to aid motor recovery), fluoxetine (an anti-depressant and anxiolytic) and low molecular weight heparin (for prevention of deep vein thrombosis post-stroke).
Related Concept Videos
Ischemic Stroke l: Introduction
Clinical Trials: Overview
